# Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

> **NCT00066274** · PHASE2 · COMPLETED · sponsor: **UNICANCER**

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** FOLFIRI regimen
- **DRUG:** FOLFOX regimen
- **DRUG:** fluorouracil
- **DRUG:** irinotecan hydrochloride
- **DRUG:** leucovorin calcium
- **DRUG:** oxaliplatin

## Key facts

- **NCT ID:** NCT00066274
- **Lead sponsor:** UNICANCER
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07-23
- **Primary completion:** 2005-11-04
- **Final completion:** 2007-04-01
- **Target enrollment:** — (—)
- **Last updated:** 2021-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00066274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00066274, "Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00066274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*